Target intelligence / Profile preview

Brain-gut-spleen axis (BGSA)

Target
BGSA
Molecular classification
Other
01

Overview

The brain-gut-spleen axis is a complex bidirectional communication network that integrates the central nervous system, the gastrointestinal tract, and the immune system to maintain systemic homeostasis (Teratani et al., 2020, Nature). This axis primarily operates through the vagus nerve and the hypothalamic-pituitary-adrenal (HPA) axis, which transmit signals from the brain and gut to the spleen, a critical site for the regulation of systemic immunity (Bronte & Pittet, 2013, Immunity). A central component of this signaling is the "cholinergic anti-inflammatory pathway," where neural impulses in the vagus nerve trigger the release of acetylcholine in the spleen, which then binds to alpha-7 nicotinic acetylcholine receptors on macrophages to inhibit the production of pro-inflammatory cytokines like TNF-alpha (Pavlov & Tracey, 2012, Nature Reviews Endocrinology). Dysregulation of the brain-gut-spleen axis is implicated in the pathogenesis of various conditions, including inflammatory bowel disease, rheumatoid arthritis, sepsis, and certain neuropsychiatric disorders (Ji et al., 2014, Scientific Reports). While the axis itself is a physiological system rather than a single molecular target, therapeutic strategies such as bioelectronic vagus nerve stimulation and pharmacological modulation of neuroendocrine receptors are being explored to treat chronic inflammatory and autoimmune diseases (Koopman et al., 2016, PNAS).

Other names
Brain-gut-immune axisNeuro-immune-endocrine axisVagus-splenic nerve axisBrain-gut-microbiota-immune axis
02

Mechanism of action

Modulation of the cholinergic anti-inflammatory pathway via vagal efferents and the hypothalamic-pituitary-adrenal (HPA) axis to regulate splenic cytokine production and systemic immune homeostasis.

03

Biological functions

Immune responseSignal transductionNeuroendocrine signalingStress responseHomeostasis
04

Disease associations

InflammationInfectionAutoimmune diseaseNeurodegenerative diseaseOther
05

Safety considerations

Systemic immunosuppressionAutonomic nervous system dysregulationSurgical risks of device implantationHormonal imbalances
06

Interacting drugs

Vagus nerve stimulation (Bioelectronic device)

4 more in the full profile.

07

Biomarkers

CortisolTumor necrosis factor-alpha (TNF-α)Interleukin-6 (IL-6)Heart rate variability (HRV)C-reactive protein (CRP)

Beyond the preview

Go deeper on Brain-gut-spleen axis (BGSA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain-gut-spleen axis (BGSA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call